---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-019872"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:07:37.530045+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bioventus completes sale of Wound Business for $35M cash + up to $45M earn-out; net ~$30M for debt

## Summary
- Closed divestiture of TheraSkin and TheraGenesis to LifeNet Health on May 22, 2023.
- Received $35M cash at close, $5M deferred 18 months, up to $45M earn-out through 2026.
- Net proceeds of ~$30M after adjustments and fees used to repay existing debt.
- Exclusive Sales Agent Agreement gives LifeNet Health rights to SonicOne in US and Canada.
- Pro forma Q1 2023 net sales from continuing ops $112.2M; net loss from cont ops $78.2M.

## SEC filing metadata
- accession: 0001628280-23-019872
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/0001628280-23-019872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/bvs-20230522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-019872
- JSON: https://secwatch.observer/filing/0001628280-23-019872.json
- Plain text: https://secwatch.observer/filing/0001628280-23-019872.txt

## Key facts
- M&A Transactions
  Bioventus Inc. completed a disposition involving LifeNet Health for $35.0 million (closed 2023-05-22).
  - Action: disposition
  - Counterparty: LifeNet Health
  - Consideration: $35.0 million
  - Closing: 2023-05-22
  source text: On May 22, 2023 , the Transaction closed (the “Closing”) and the Sellers received a cash payment of $35.0 million subject to customary post-closing adjustments for working capital.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000162828023019872/0001628280-23-019872-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.